OTC:RAPH | Income Statement | Raphael Pharmaceutical Inc.

Complete source-backed income-statement history.

Available history
2020-09-30 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$40,000.00-$199,000.00-$24,000.00-$223,000.00$0.01$0.0120,176,41820,176,418
2026-03-31$37,000.00-$223,000.00-$6,000.00-$229,000.00$0.01$0.0120,176,41820,176,418
2025-12-31$345,000.00-$254,000.00-$19,000.00-$273,000.00$0.02$0.0294,95394,953
2025-09-30$73,000.00-$251,000.00-$4,000.00-$255,000.00$0.01$0.0119,626,41819,626,418
2025-06-30$141,000.00-$315,000.00-$7,000.00-$322,000.00$0.02$0.0219,626,41819,626,418
2025-03-31$72,000.00-$425,000.00-$4,000.00-$429,000.00$0.02$0.0219,626,41819,626,418
2024-12-31$211,000.00-$394,000.00-$1,000.00-$395,000.00$0.02$0.0227,19427,194
2024-09-30$162,000.00-$319,000.00-$7,000.00-$326,000.00$0.01$0.0118,701,41818,701,418
2024-06-30$24,000.00-$249,000.00$1,000.00-$248,000.00$0.01$0.0118,676,08418,676,084
2024-03-31$379,000.00-$547,000.00-$3,000.00-$550,000.00$0.03$0.0318,616,55118,616,551
2023-12-31-$348,000.00$74,000.00$62,000.00-$0.01-$0.01542,247542,247
2023-09-30$510,000.00-$729,000.00$4,000.00-$725,000.00$0.04$0.0416,444,39916,444,399
2023-06-30$293,000.00-$419,000.00$2,000.00-$417,000.00$0.03$0.0316,109,51416,109,514
2023-03-31$114,000.00-$258,000.00-$6,000.00-$264,000.00$0.02$0.0215,964,48915,964,489
2022-12-31$676,000.00-$1.1M$1,000.00-$1.1M$0.07$0.07420,412420,412
2022-09-30$332,000.00-$1.43M-$17,000.00-$1.44M$0.10$0.1015,061,90215,061,902
2022-06-30$84,000.00-$612,000.00-$15,000.00-$627,000.00$0.05$0.0513,647,15113,647,151
2022-03-31$86,000.00-$175,000.00-$10,000.00-$185,000.00$0.01$0.0113,035,37113,035,371
2021-12-31$224,000.00-$574,000.00$8,000.00-$566,000.00$0.05$0.05360,690360,690
2021-09-30$161,000.00-$418,000.00$2,000.00-$416,000.00$0.03$0.0312,131,66312,131,663
2021-06-30$222,000.00-$385,000.00-$2,000.00-$387,000.00$0.04$0.0410,813,64910,813,649
2021-03-31$169,000.00-$252,000.00-$3,000.00-$255,000.00$0.029,459,253
2020-12-31$220,000.00-$227,000.00-$3,000.00-$230,000.000
2020-09-30$69,000.00-$235,000.00-$8,000.00-$243,000.009,459,253

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$631,000.00-$1.25M-$34,000.00-$1.28M$0.07$0.0719,551,71919,551,719
2024-12-31$776,000.00-$1.51M-$10,000.00-$1.52M$0.08$0.0818,674,13618,674,136
2023-12-31$569,000.00-$1.33M-$12,000.00-$1.34M$0.08$0.0816,716,90516,716,905
2022-12-31$1.18M-$3.32M-$41,000.00-$3.36M$0.23$0.2314,341,51814,341,518
2021-12-31$776,000.00-$1.63M$5,000.00-$1.62M$0.14$0.1411,171,70411,171,704
2020-12-31$461,000.00-$706,000.00-$12,000.00-$718,000.009,459,253

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.